tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
US Market
APLS
Apellis Pharmaceuticals
RESEARCH TOOLSreports

Apellis Pharmaceuticals (APLS) Stock News & Sentiment

Compare
999 Followers
Apellis Pharmaceuticals Balances Growth With Revenue Headwinds
Premium
Company Announcements
Apellis Pharmaceuticals Balances Growth With Revenue Headwinds
17d ago
APLS
Apellis Pharmaceuticals Adds Mikael Dolsten to Board
Premium
Company Announcements
Apellis Pharmaceuticals Adds Mikael Dolsten to Board
22d ago
8K
APLS
Balanced Outlook on Apellis: Near-Term Revenue Uncertainty and Developing Long-Term Upside Justify Hold Rating
Premium
Ratings
Balanced Outlook on Apellis: Near-Term Revenue Uncertainty and Developing Long-Term Upside Justify Hold Rating
27d ago
APLS
Apellis Pharmaceuticals: Buy Rating Supported by Blockbuster Empaveli Potential, Sustainable Syfovre Growth, and Expanding Kidney Franchise
Premium
Ratings
Apellis Pharmaceuticals: Buy Rating Supported by Blockbuster Empaveli Potential, Sustainable Syfovre Growth, and Expanding Kidney Franchise
27d ago
APLS
Apellis Pharmaceuticals: Solid Syfovre Franchise and Rapid Empaveli Uptake Underpin Buy Rating and Long-Term Upside
Premium
Ratings
Apellis Pharmaceuticals: Solid Syfovre Franchise and Rapid Empaveli Uptake Underpin Buy Rating and Long-Term Upside
27d ago
APLS
APLS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
APLS Earnings this Week: How Will it Perform?
30d ago
APLS
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
Premium
Weekend Updates
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
2M ago
APLS
IMVT
More APLS News >

APLS News on the Web

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
The Motley Fool
Neutral
Why Apellis Pharmaceuticals Stock Is Sliding Today
TipRanks News
Neutral
Cantor Fitzgerald Reaffirms Their Buy Rating on Apellis Pharmaceuticals (APLS)
TipRanks News
Neutral
Apellis price target lowered to $31 from $35 at Cantor Fitzgerald
TipRanks News
Bearish
Apellis Pharmaceuticals (APLS) Receives Buy Rating Amid Growth Prospects
GuruFocus News
Bullish
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
TipRanks News
Bullish
Apellis price target raised to $20 from $19 at Mizuho
TipRanks News
Neutral
Apellis initiated with a Buy at Roth Capital
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
APLS
Sector Average
Media Buzz
This Week4 articles
Weekly Average8.75 articles
News Sentiment
This Week0%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APLS’s Media Buzz Sentiment?
4 articles about APLS were published this week. In an average week, 8.75 articles are published.
    What is APLS’s weekly average amount of articles?
    In an average week, 8.75 articles about APLS are published.
      What is APLS’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      HYPRHyperfine
      OVIDOvid Therapeutics
      ALMSAlumis Inc.
      INNMFAmplia Therapeutics
      PBHPrestige Consumer Healthcare
      Showing the stocks with the most bullish news sentiment over the past week